New pill aims to calm ulcerative colitis flare-ups in korean patients
NCT ID NCT06964113
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a daily medication called filgotinib (200 mg) in about 94 Korean adults with moderate-to-severe ulcerative colitis. The main goal is to see if it can bring the disease into remission (no active symptoms) by week 10 or 22. Participants take the pill once daily and are monitored for up to 58 weeks. This is an open-label study, meaning everyone knows they are getting the active drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Eisai Site #1
RECRUITINGSeoul, South Korea
-
Eisai Site #10
RECRUITINGSeoul, South Korea
-
Eisai Site #11
RECRUITINGGyeongnam, South Korea
-
Eisai Site #12
RECRUITINGSeoul, South Korea
-
Eisai Site #13
RECRUITINGBusan, South Korea
-
Eisai Site #14
RECRUITINGSeoul, South Korea
-
Eisai Site #15
RECRUITINGBusan, South Korea
-
Eisai Site #16
RECRUITINGGyeonggi-do, South Korea
-
Eisai Site #17
RECRUITINGSeoul, South Korea
-
Eisai Site #18
RECRUITINGJungnam, South Korea
-
Eisai Site #19
RECRUITINGSeoul, South Korea
-
Eisai Site #2
RECRUITINGDaejeon, South Korea
-
Eisai Site #3
RECRUITINGSeoul, South Korea
-
Eisai Site #4
RECRUITINGGyeonggi-do, South Korea
-
Eisai Site #5
RECRUITINGSeoul, South Korea
-
Eisai Site #6
RECRUITINGDaegu, South Korea
-
Eisai Site #7
RECRUITINGJungnam, South Korea
-
Eisai Site #8
RECRUITINGBusan, South Korea
-
Eisai Site #9
RECRUITINGSeoul, South Korea